Single award · contract
Advanced Development of Recombinant Protective Antigent (RPA) Anthrax Vaccine Can 1990087
Award ID: HHSO100201000059C
A single federal award, with both ends of the trail linked.
$93M
Total award value
Award HHSO100201000059C is a contract from the Department of Health and Human Services to Emergent Product Development Gaithersburg Inc., $93M obligated, FY2010 to FY2022, for Advanced Development of Recombinant Protective Antigent (RPA) Anthrax Vaccine Can 1990087. The work is performed in Maryland. It is classified as PSC C118 (Research and Development Facilities) and NAICS 541711 (Research and Development in Biotechnology). Source
Description
TAS::75 0140::TAS Advanced Development of Recombinant Protective Antigent (RPA) Anthrax Vaccine Can 1990087
Award details
Award typeContract
PIIDHHSO100201000059C
Action date2010
Period141 mo
Awarding agencyDepartment of Health and Human Services →
Place of performanceMaryland →
CategoryPSC C118NAICS 541711
Competed?Not recordedSource
Total (exact)$92,988,270
More from Department of Health and Human Services
awarded 2025$110.4B
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.